Report Detail
Global Plasma Fractionation Market Insights, Forecast to 2025
- RnM3206347 |
- 04 April, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
North America is the largest supplier of Plasma Fractionation, with production revenue market share about 60%, and the sales market share is 44% in 2015. That is to say, there are a large number of exports in North America, while North America also is the largest consumption region.
Europe, following North America, takes production revenue market share of 20% and the sales market share over 20% in 2015. China is an important market of Plasma Fractionation in Asia, accounting for 11% production revenue market share and 12% sales revenue market share of global market in 2015.
Japan has production revenue market share of 5% and sales revenue market share of 7% nearly in 2015. The local production can meet most local demand, and there is a small amount of imports.
Baxter, CSL, Grifols are the leaders of the industry, with 65% market share in 2015, and hold key technologies and patents. Other manufactures’ products are used to meet local demand. With further expanding market, there will be more players in the future.
The global Plasma Fractionation market is valued at 28900 million US$ in 2018 and will reach 63000 million US$ by the end of 2025, growing at a CAGR of 10.2% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Plasma Fractionation market based on company, product type, end user and key regions.
This report studies the global market size of Plasma Fractionation in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Plasma Fractionation in these regions.
This research report categorizes the global Plasma Fractionation market by top players/brands, region, type and end user. This report also studies the global Plasma Fractionation market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Baxter
CSL
Grifols
Octapharma
BPL
Kedrion
Mitsubishi Tanabe
CBOP
RAAS
Hualan Bio
Market size by Product
Albumin
Immune Globulin
Coagulation Factor
Market size by End User
Immunity
Therapy
Surgery
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Plasma Fractionation market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Plasma Fractionation market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Plasma Fractionation companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Plasma Fractionation submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Plasma Fractionation are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Plasma Fractionation market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Plasma Fractionation Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Plasma Fractionation Market Size Growth Rate by Product
- 1.4.2 Albumin
- 1.4.3 Immune Globulin
- 1.4.4 Coagulation Factor
- 1.5 Market by End User
- 1.5.1 Global Plasma Fractionation Market Size Growth Rate by End User
- 1.5.2 Immunity
- 1.5.3 Therapy
- 1.5.4 Surgery
- 1.5.5 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Plasma Fractionation Market Size
- 2.1.1 Global Plasma Fractionation Revenue 2014-2025
- 2.1.2 Global Plasma Fractionation Sales 2014-2025
- 2.2 Plasma Fractionation Growth Rate by Regions
- 2.2.1 Global Plasma Fractionation Sales by Regions
- 2.2.2 Global Plasma Fractionation Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Plasma Fractionation Sales by Manufacturers
- 3.1.1 Plasma Fractionation Sales by Manufacturers
- 3.1.2 Plasma Fractionation Sales Market Share by Manufacturers
- 3.1.3 Global Plasma Fractionation Market Concentration Ratio (CR5 and HHI)
- 3.2 Plasma Fractionation Revenue by Manufacturers
- 3.2.1 Plasma Fractionation Revenue by Manufacturers (2014-2019)
- 3.2.2 Plasma Fractionation Revenue Share by Manufacturers (2014-2019)
- 3.3 Plasma Fractionation Price by Manufacturers
- 3.4 Plasma Fractionation Manufacturing Base Distribution, Product Types
- 3.4.1 Plasma Fractionation Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Plasma Fractionation Product Type
- 3.4.3 Date of International Manufacturers Enter into Plasma Fractionation Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Plasma Fractionation Sales by Product
- 4.2 Global Plasma Fractionation Revenue by Product
- 4.3 Plasma Fractionation Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Plasma Fractionation Breakdown Data by End User
6 North America
- 6.1 North America Plasma Fractionation by Countries
- 6.1.1 North America Plasma Fractionation Sales by Countries
- 6.1.2 North America Plasma Fractionation Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Plasma Fractionation by Product
- 6.3 North America Plasma Fractionation by End User
7 Europe
- 7.1 Europe Plasma Fractionation by Countries
- 7.1.1 Europe Plasma Fractionation Sales by Countries
- 7.1.2 Europe Plasma Fractionation Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Plasma Fractionation by Product
- 7.3 Europe Plasma Fractionation by End User
8 Asia Pacific
- 8.1 Asia Pacific Plasma Fractionation by Countries
- 8.1.1 Asia Pacific Plasma Fractionation Sales by Countries
- 8.1.2 Asia Pacific Plasma Fractionation Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Plasma Fractionation by Product
- 8.3 Asia Pacific Plasma Fractionation by End User
9 Central & South America
- 9.1 Central & South America Plasma Fractionation by Countries
- 9.1.1 Central & South America Plasma Fractionation Sales by Countries
- 9.1.2 Central & South America Plasma Fractionation Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Plasma Fractionation by Product
- 9.3 Central & South America Plasma Fractionation by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Plasma Fractionation by Countries
- 10.1.1 Middle East and Africa Plasma Fractionation Sales by Countries
- 10.1.2 Middle East and Africa Plasma Fractionation Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Plasma Fractionation by Product
- 10.3 Middle East and Africa Plasma Fractionation by End User
11 Company Profiles
- 11.1 Baxter
- 11.1.1 Baxter Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Baxter Plasma Fractionation Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Baxter Plasma Fractionation Products Offered
- 11.1.5 Baxter Recent Development
- 11.2 CSL
- 11.2.1 CSL Company Details
- 11.2.2 Company Business Overview
- 11.2.3 CSL Plasma Fractionation Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 CSL Plasma Fractionation Products Offered
- 11.2.5 CSL Recent Development
- 11.3 Grifols
- 11.3.1 Grifols Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Grifols Plasma Fractionation Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Grifols Plasma Fractionation Products Offered
- 11.3.5 Grifols Recent Development
- 11.4 Octapharma
- 11.4.1 Octapharma Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Octapharma Plasma Fractionation Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Octapharma Plasma Fractionation Products Offered
- 11.4.5 Octapharma Recent Development
- 11.5 BPL
- 11.5.1 BPL Company Details
- 11.5.2 Company Business Overview
- 11.5.3 BPL Plasma Fractionation Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 BPL Plasma Fractionation Products Offered
- 11.5.5 BPL Recent Development
- 11.6 Kedrion
- 11.6.1 Kedrion Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Kedrion Plasma Fractionation Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Kedrion Plasma Fractionation Products Offered
- 11.6.5 Kedrion Recent Development
- 11.7 Mitsubishi Tanabe
- 11.7.1 Mitsubishi Tanabe Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Mitsubishi Tanabe Plasma Fractionation Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Mitsubishi Tanabe Plasma Fractionation Products Offered
- 11.7.5 Mitsubishi Tanabe Recent Development
- 11.8 CBOP
- 11.8.1 CBOP Company Details
- 11.8.2 Company Business Overview
- 11.8.3 CBOP Plasma Fractionation Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 CBOP Plasma Fractionation Products Offered
- 11.8.5 CBOP Recent Development
- 11.9 RAAS
- 11.9.1 RAAS Company Details
- 11.9.2 Company Business Overview
- 11.9.3 RAAS Plasma Fractionation Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 RAAS Plasma Fractionation Products Offered
- 11.9.5 RAAS Recent Development
- 11.10 Hualan Bio
- 11.10.1 Hualan Bio Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Hualan Bio Plasma Fractionation Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Hualan Bio Plasma Fractionation Products Offered
- 11.10.5 Hualan Bio Recent Development
12 Future Forecast
- 12.1 Plasma Fractionation Market Forecast by Regions
- 12.1.1 Global Plasma Fractionation Sales Forecast by Regions 2019-2025
- 12.1.2 Global Plasma Fractionation Revenue Forecast by Regions 2019-2025
- 12.2 Plasma Fractionation Market Forecast by Product
- 12.2.1 Global Plasma Fractionation Sales Forecast by Product 2019-2025
- 12.2.2 Global Plasma Fractionation Revenue Forecast by Product 2019-2025
- 12.3 Plasma Fractionation Market Forecast by End User
- 12.4 North America Plasma Fractionation Forecast
- 12.5 Europe Plasma Fractionation Forecast
- 12.6 Asia Pacific Plasma Fractionation Forecast
- 12.7 Central & South America Plasma Fractionation Forecast
- 12.8 Middle East and Africa Plasma Fractionation Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Plasma Fractionation Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Plasma Fractionation . Industry analysis & Market Report on Plasma Fractionation is a syndicated market report, published as Global Plasma Fractionation Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Plasma Fractionation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
